A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection

Clinical trial NCT01939197 · COMPLETED

Trial details

NCT number: NCT01939197
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Hepatitis C Virus Infection Human Immunodeficiency Virus Infection Chronic Hepatitis C Compensated Cirrhosis and Non-cirrhotics

Start date: 2013-08-30
Primary completion: 2016-07-21
Enrollment: 318

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.